News We’re Watching: Medicare Prepares To Release TCET, Regulatory Clearances For Medasense and Methinks AI
Executive Summary
A new regulatory agenda from the US Department of Health and Human Services shows that a proposed rule coverage for breakthrough devices is expected in the near future. Additionally, new technology to monitor patent pain during surgery and triage stroke patients got regulatory approvals, and the US FDA added to its webpage on device misconnections.
You may also be interested in...
US Representatives Urge CMS To Insure Coverage Of Breakthrough Technology By Year’s End
Four US representatives sent a letter to CMS urging them to pass a the TCET proposed rule by the end of 2022.
EU MDR Notified Bodies Reach 38 After Another Designation
Germany’s SZUTEST is the latest notified body to be designated under the EU Medical Device Regulation, bringing the total number to 38.
News We’re Watching – FDA Mammography Update, SVB Collapse, Zoll's Data Breach, And More
News we are keeping an eye on this week includes the FDA’s first traditional market authorization for a COVID-19 test and its approval of a new neurological diagnostic. The agency also updated its device shortage list and revised mammography guidelines.